Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

CPhI Worldwide

Brexit talks threaten supply of medical technologies

As concern grows that the outcome could undermine the regulatory framework

- PMLiVE

UK pharma welcomes Brexit breakthrough

Calls for medicines regulation and supply to be a priority in talks' next stage

- PMLiVE

UK trumpets life sciences post-Brexit ‘sector deal’

Highlights commitments from GlaxoSmithKline, AstraZeneca and MSD

- PMLiVE

MSD to create strong UK discovery centre in London

The pharma group aims to start operations by 2020

- PMLiVE

Amsterdam picked to host the European Medicines Agency

But regulator faces a “challenging” relocation project to depart from London

- PMLiVE

Pulling together

Making sense of the present and future environment for the life science sector in the UK

- PMLiVE

Moving times

Continuity and stability are vital when it comes to the EMA's relocation when it leaves London

- PMLiVE

Freedom of movement ‘unlocks’ scientific success

Nature study finds mobility gave researchers higher citation rates than those who remained in their homeland

- PMLiVE

EMA sets aside £32m for temporary staff to help with Brexit move

As agency warns current tender system needs to be updated

- PMLiVE

Hard Brexit could cost UK healthcare sector £2bn per year

Pharma and medical supply firms may face 10% revenue drop

Brexit implications for UK pharma legislation

What are the potential options and outcomes of the negotiations?

- PMLiVE

EMA faces ‘permanent damage’ if forced to go to an unpopular city

Warns eight candidate cities wouldn't retain minimum staff numbers it needs

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links